Benign prostatic hyperplasia: an insight into current investigational medical therapies

Author： Tiwari Atul   Krishna N S   Nanda Kamna   Chugh Anita  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.14, Iss.11, 2005-11, pp. : 1359-1372

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Investigational therapies targeted to the treatment of benign prostatic hyperplasia

By Gravas Stavros   de la Rosette Jean JMCH  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 3, 2013-03 ,pp. : 357-368

Informa Healthcare

Access to resources Recommend Favorite

Combination Pharmacological Therapies for the Management of Benign Prostatic Hyperplasia

By Cohen Seth A.   Parsons J. Kellogg  

Drugs & Aging, Vol. 29, Iss. 4, 2012-04 ,pp. : 275-284

Adis International

Access to resources Recommend Favorite

Emerging drug therapies for benign prostatic hyperplasia

By Bullock Travis L   Andriole Jr Gerald L  

Expert Opinion on Emerging Drugs, Vol. 11, Iss. 1, 2006-03 ,pp. : 111-123

Informa Healthcare

Access to resources Recommend Favorite

NX-1207: a novel investigational drug for the treatment of benign prostatic hyperplasia

By Shore Neal  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 2, 2010-02 ,pp. : 305-310

Informa Healthcare

Access to resources Recommend Favorite

Current concepts in the pharmacotherapy of benign prostatic hyperplasia

By Khastgir Jay   Arya Manit   Shergill Iqbal S   Kalsi Jas S   Minhas Sux   Mundy AnthonyR  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 12, 2002-12 ,pp. : 1727-1737

Informa Healthcare

Access to resources Recommend Favorite